BPA Call HT001415A0024-0005
Award Date
10/19/15
Potential Completion Date
9/30/16
Potential Value
$300K
Federal Agency
Defense Health Agency
Awardee
The Compounding Center Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Health Agency, a defense agency, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, for the provision of specialized pharmaceuticals and compounded medications to address drug shortages. The $400,000 firm fixed price contract has an ultimate completion date of September 30, 2016 and does not utilize a set-aside designation. The Compounding Center has received over $700,000 in prior awards from the...
This federal contract award was issued by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The $400,000 firm fixed price contract is for the delivery of various shortage pharmaceuticals to support patient care at military hospitals and clinics. The contract has no set-aside designation. The Compounding Center Inc. has received over $700,000 in previous contract awards from the...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide specialized pharmaceuticals and compounded medications to address shortages impacting patient care at military and civilian treatment facilities. The $400,000 contract has a period of performance through September 30, 2016 and is not designated as a small business set-aside. The Compounding Center...
The Defense Health Agency awarded a firm fixed price contract to The Compounding Center Inc., a minority-owned and self-certified small disadvantaged business, to provide various shortage pharmaceutical items including blood products, oncological pharmaceuticals, injectables, orals, and inhalations. The $300,000.00 contract is a Blanket Purchase Agreement (BPA) Call with a performance period ending September 30, 2019. The Compounding Center, a for-profit Subchapter S corporation, has also...
The Defense Health Agency awarded a firm-fixed-price blanket purchase agreement (BPA) call worth $300,000.00 to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The contract is for the supply of shortage pharmaceuticals and blood products, as well as oncological pharmaceuticals and other relevant pharmaceutical products including injectables, orals, and medicinal inhalations. The Compounding Center will deliver these specialized medications and...
The U.S. Defense Health Agency awarded a $100,000.00 firm fixed price blanket purchase agreement call to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The contract is for the supply of shortage pharmaceuticals such as vinblastine, NovoSeven, and other relevant injectable, oral, and inhalation medications to support military and civilian treatment facilities. The Compounding Center has received over $700,000 in prior awards from the Department of...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call award made by the Defense Health Agency (DHA) to The Compounding Center Inc., a minority-owned, small disadvantaged business. The $400,000 award is for the delivery of specialized pharmaceuticals and compounded medications to address drug shortages impacting patient care at military and civilian treatment facilities. The Compounding Center has received over $700,000 in prior awards from the Department of Health and Human Services...
This is a firm fixed price contract awarded by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide specialized pharmaceutical compounds and medications to address shortages impacting patient care at military and civilian treatment facilities. The $650,000 contract is a blanket purchase agreement (BPA) call that allows for the expedited acquisition of customized drugs and...
The Defense Health Agency awarded a firm fixed price blanket purchase agreement (BPA) call to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide prescription pharmaceuticals such as vinblastine, carimune, and oncological medications. The $250,000 contract has no set-aside designation and supports the urgent needs of military treatment facilities, including Walter Reed National Military Medical Center, by delivering specialized, customized...
This contract award is for the delivery of various shortage pharmaceuticals to the Defense Health Agency, an agency within the Department of Defense. The prime contractor, The Compounding Center Inc., is a minority-owned, small disadvantaged business that provides specialized pharmaceutical compounds and medical supplies to government agencies. The contract is a blanket purchase agreement with a ceiling value of $300,000.00, allowing for the expedited acquisition of customized medications and...